Geneva, June 22 -- International Clinical Trials Registry received information related to the study (ChiCTR2600126433) titled 'Effects of Remimazolam Besylate-Based Total Intravenous Anesthesia on Postoperative Sleep Quality and Quality of Recovery in Patients Undergoing Endoscopic Lumbar Spine Surgery' on June 9.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Ordos Central Hospital
Condition:
None
Intervention:
Remimazolam Group:Induction phase: remimazolam 0.2 mg/kg + sufentanil 0.5 µg/kg + cisatracurium 0.15 mg/kg.
Maintenance phase: remimazolam 1 mg/(kg·h) + remifentanil 0.2 µg/(kg·h).
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2025-01-22
Target Sa...